Immunovant
IMVT
#2550
Rank
NZ$12.50 B
Marketcap
NZ$60.43
Share price
-0.12%
Change (1 day)
44.35%
Change (1 year)

Earnings for Immunovant (IMVT)

Earnings in 2026 (TTM): -NZ$0.99 Billion

According to Immunovant's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.89 Billion a decrease over its 2024 earnings that were of -NZ$0.74 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Immunovant from 2019 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.99 Billion10.93%
2025 -NZ$0.89 Billion20.23%
2024 -NZ$0.74 Billion59.79%
2023 -NZ$0.47 Billion32.6%
2022 -NZ$0.35 Billion39.55%
2021 -NZ$0.25 Billion37.3%
2020 -NZ$0.19 Billion780.74%
2019 -NZ$20.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.29 Billion-72.41%๐Ÿ‡บ๐Ÿ‡ธ USA